CymaBay Therapeutics Inc.

NASDAQ: CBAY · Real-Time Price · USD
32.48
0.01 (0.03%)
At close: Mar 21, 2024, 9:00 PM

CymaBay Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
206.53M 20.29M 125.81M
Short-Term Investments
187.72M 115.19M 60.73M
Long-Term Investments
22.36M n/a 8.07M
Other Long-Term Assets
2.8M 2.91M 1.72M
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
9.55M 2.59M 4.56M
Total Current Assets
403.8M 138.07M 191.1M
Property-Plant & Equipment
5.72M 870K 1.43M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
30.88M 3.78M 11.22M
Total Assets
434.69M 141.85M 202.32M
Account Payables
3.83M 1.1M 2.73M
Deferred Revenue
1.69M n/a n/a
Short-Term Debt
10.01M 664K 567K
Other Current Liabilities
21.32M 13.68M 15.07M
Total Current Liabilities
36.84M 15.44M 18.37M
Long-Term Debt
104.49M 90.26M 51.02M
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
105.59M 90.26M 51.02M
Total Liabilities
142.43M 105.7M 69.38M
Total Debt
114.49M 90.92M 51.58M
Common Stock
11K 8K 8K
Retained Earnings
-978.23M -872.86M -766.86M
Comprehensive Income
144K -326K -13K
Shareholders Equity
292.26M 36.15M 132.94M
Total Investments
210.08M 115.19M 68.8M